Impact of empagliflozin on cardiac structure and function assessed by echocardiography after myocardial infarction: a post-hoc sub-analysis of the emmy trial.

Here, though not reaching statistical significance, a favorable trend towards empagliflozin was observed regarding left ventricular strain, which was more pronounced in the HFpEF group (adjusted mean treatment difference, 2.18% [SE, 1.16 (95% CI, − 0.28 to 4.64)]; p = 0.08) [ 34 ].

also in 1,335 other papers